BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9671751)

  • 1. Mitogen-activated protein kinases enhance long-range activation by the beta-globin locus control region.
    Versaw WK; Blank V; Andrews NM; Bresnick EH
    Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8756-60. PubMed ID: 9671751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirements for utilization of CREB binding protein by hypersensitive site two of the beta-globin locus control region.
    Johnson KD; Norton JE; Bresnick EH
    Nucleic Acids Res; 2002 Apr; 30(7):1522-30. PubMed ID: 11917012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of beta-globin locus control region-mediated transactivation by mitogen-activated protein kinases through stochastic and graded mechanisms.
    Forsberg EC; Zaboikina TN; Versaw WK; Ahn NG; Bresnick EH
    Mol Cell Biol; 1999 Aug; 19(8):5565-75. PubMed ID: 10409746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct interaction of NF-E2 with hypersensitive site 2 of the beta-globin locus control region in living cells.
    Forsberg EC; Downs KM; Bresnick EH
    Blood; 2000 Jul; 96(1):334-9. PubMed ID: 10891470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirement of an E1A-sensitive coactivator for long-range transactivation by the beta-globin locus control region.
    Forsberg EC; Johnson K; Zaboikina TN; Mosser EA; Bresnick EH
    J Biol Chem; 1999 Sep; 274(38):26850-9. PubMed ID: 10480893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF-E2 disrupts chromatin structure at human beta-globin locus control region hypersensitive site 2 in vitro.
    Armstrong JA; Emerson BM
    Mol Cell Biol; 1996 Oct; 16(10):5634-44. PubMed ID: 8816476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential role of NF-E2 in remodeling of chromatin structure and transcriptional activation of the epsilon-globin gene in vivo by 5' hypersensitive site 2 of the beta-globin locus control region.
    Gong QH; McDowell JC; Dean A
    Mol Cell Biol; 1996 Nov; 16(11):6055-64. PubMed ID: 8887635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of beta-major globin gene transcription is associated with recruitment of NF-E2 to the beta-globin LCR and gene promoter.
    Sawado T; Igarashi K; Groudine M
    Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10226-31. PubMed ID: 11517325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A major role for the TATA box in recruitment of chromatin modifying complexes to a globin gene promoter.
    Gui CY; Dean A
    Proc Natl Acad Sci U S A; 2003 Jun; 100(12):7009-14. PubMed ID: 12773626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The activation domain of the enhancer binding protein p45NF-E2 interacts with TAFII130 and mediates long-range activation of the alpha- and beta-globin gene loci in an erythroid cell line.
    Amrolia PJ; Ramamurthy L; Saluja D; Tanese N; Jane SM; Cunningham JM
    Proc Natl Acad Sci U S A; 1997 Sep; 94(19):10051-6. PubMed ID: 9294161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancer activity of HS2 of the human beta-LCR is modulated by distance from the key nucleosome.
    Onishi Y; Kiyama R
    Nucleic Acids Res; 2001 Aug; 29(16):3448-57. PubMed ID: 11504883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conserved elements containing NF-E2 and tandem GATA binding sites are required for erythroid-specific chromatin structure reorganization within the human beta-globin locus control region.
    Pomerantz O; Goodwin AJ; Joyce T; Lowrey CH
    Nucleic Acids Res; 1998 Dec; 26(24):5684-91. PubMed ID: 9838000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The beta -globin locus control region (LCR) functions primarily by enhancing the transition from transcription initiation to elongation.
    Sawado T; Halow J; Bender MA; Groudine M
    Genes Dev; 2003 Apr; 17(8):1009-18. PubMed ID: 12672691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-copy transduction and expression of human gamma-globin in K562 erythroleukemia cells using recombinant adeno-associated virus vectors: the effect of mutations in NF-E2 and GATA-1 binding motifs within the hypersensitivity site 2 enhancer.
    Miller JL; Walsh CE; Ney PA; Samulski RJ; Nienhuis AW
    Blood; 1993 Sep; 82(6):1900-6. PubMed ID: 8400240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A WW domain-binding motif within the activation domain of the hematopoietic transcription factor NF-E2 is essential for establishment of a tissue-specific histone modification pattern.
    Kiekhaefer CM; Boyer ME; Johnson KD; Bresnick EH
    J Biol Chem; 2004 Feb; 279(9):7456-61. PubMed ID: 14597626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-E2 and GATA binding motifs are required for the formation of DNase I hypersensitive site 4 of the human beta-globin locus control region.
    Stamatoyannopoulos JA; Goodwin A; Joyce T; Lowrey CH
    EMBO J; 1995 Jan; 14(1):106-16. PubMed ID: 7828582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and functional cross-talk between a distant enhancer and the epsilon-globin gene promoter shows interdependence of the two elements in chromatin.
    McDowell JC; Dean A
    Mol Cell Biol; 1999 Nov; 19(11):7600-9. PubMed ID: 10523648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dependence of globin gene expression in mouse erythroleukemia cells on the NF-E2 heterodimer.
    Kotkow KJ; Orkin SH
    Mol Cell Biol; 1995 Aug; 15(8):4640-7. PubMed ID: 7623856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional activation by hypersensitive site three of the human beta-globin locus control region in murine erythroleukemia cells.
    Pruzina S; Antoniou M; Hurst J; Grosveld F; Philipsen S
    Biochim Biophys Acta; 1994 Oct; 1219(2):351-60. PubMed ID: 7918632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maximal activity of an erythroid-specific enhancer requires the presence of specific protein binding sites in linked promoters.
    Amrolia PJ; Gabbard W; Cunningham JM; Jane SM
    J Biol Chem; 1998 May; 273(22):13593-8. PubMed ID: 9593696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.